March 1, 2019

Harvard Bioscience profits jump 76%

Photo | Google
Harvard Bioscience's Holliston headquarters on October Hill Road.

Revenue at Holliston medical device maker Harvard Bioscience climbed 20 percent last year, with profits rising to $7.4 million, the company said Thursday.

The company saw revenue hit $122 million, while profits rose year-over-year by 76 percent.

Harvard Bioscience's annual results cover a year when the company bought Data Sciences International of Minnesota and sold its Denville Scientific division to New Jersey-based Thomas Scientific. The company appointed biotech finance veteran Kam Unninayar as CFO in October to replace the Robert Gagnon.

The company said it expects slower growth in the year ahead, forecasting revenue of $124 million to $126.5 million.


Type your comment here:

Today's Poll Would you consider putting neurodiversity into your firm's hiring practices? <>
Most Popular on Facebook
Copyright 2017 New England Business Media